BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM;得克薩斯州大學系統董事會
发明人:
LU, Zhimin,呂志民
申请号：
HK18103904.9
公开号：
HK1244462A
申请日:
2018.03.21
申请国别(地区):
HK
年份:
2018
代理人:
摘要：
Compositions and methods for characterizing cancer cells by determining a marker of PGK1 activity. For example, methods are provided for predicting a patient response to a PGK1 inhibitor, a MEK/ERK inhibitor, an EGFR inhibitor, or a PIN1 inhibitor therapy. Methods for treating patients with such therapies are likewise provided.
